Antiangiogenic Drugs in NASH: Evidence of a Possible New Therapeutic Approach

• Main Authors: Paola Orlandi (Author), Anna Solini (Author), Marta Banchi (Author), Maurizia Rossana Brunetto (Author), Dania Cioni (Author), Lorenzo Ghiadoni (Author), Guido Bocci (Author)
• Format: Book
• Published: MDPI AG, 2021-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Non-alcoholic fatty liver disease is the most common liver disorder worldwide, and its progressive form non-alcoholic steatohepatitis (NASH) is a growing cause of liver cirrhosis and hepatocellular carcinoma (HCC). Lifestyle changes, which are capable of improving the prognosis, are hard to achieve,...